The BioCorRx® Recovery Program is an alcohol and opioid use disorder recovery program, using proprietary cognitive behavioral therapy (CBT) modules developed by BioCorRx and live peer support via mobile app that can include the use of medications commonly used to treat alcohol and opioid use disorder such as naltrexone and buprenorphine by way of examples in various forms of delivery as determined by one’s physician. The program is only available from independent medical providers who deem it necessary for their patients. BioCorRx does not diagnose, treat, or sell the program to patients or make, sell or compound any medications that may be prescribed.

Medication-Assisted Treatment (MAT)


According to a 2006 Study entitled “Combining Medications and Behavioral Interventions for Alcoholism” (COMBINE Study) conducted by the U.S. Department of Health and Human Service (HHS)’s National Institute on Alcohol Abuse and Alcoholism (NIAAA), the best outcomes in naltrexone therapy are a result of receiving naltrexone along with outpatient behavioral modification counseling.2

The BioCorRx® Recovery Program, in compliance with NIAAA and HHS guidelines, has expanded on this important concept.

Our Program


The BioCorRx® Recovery Program blends medical management by an independent physician using previously mentioned examples of commonly used medications for the treatment of opioid and alcohol use disorders with our proprietary CBT program and live peer support engagement mobile application.

One such medicine, naltrexone, by way of example, is an opioid antagonist that has been shown to help significantly reduce the cravings and/or the “pleasure feelings” typically generated in the brain when opioids or alcohol are consumed. In the case of naltrexone pellets when deemed appropriate by a physician, the biodegradable naltrexone pellet(s) releases the drug into the body over time. As stated, naltrexone can help to significantly reduce or even eliminate the cravings for, and block certain effects of, drugs and alcohol in many people. Independent treatment providers have reported that their patients experienced minimal to no physical discomfort during the procedure, which requires only local anesthetic and typically takes a short office visit to perform.

The next component of the program was developed by BioCorRx® after identifying 35 key areas essential to early treatment in Substance Use Disorders. Delivered through proprietary, detailed modules which were written by addiction experts with decades of combined experience, the program includes specific curriculum to address these 35 areas so important to effecting behavioral change in connection with Substance Use Disorders. While the program was initially designed for use with those being treating with naltrexone, it can now be utilized in conjunction with buprenorphine therapy, as prescribed and recommended by the treating physician. It can also be used for those not on medication treatment as well. Credentialed addiction professionals must meet certain criteria before they can access and utilize the BioCorRx® CBT Program. Participants generally complete the modules within 90 days of beginning their physician prescribed medication treatment.

Additionally, BioCorRx® has expanded the support structure to include 6 months of a live peer-support system utilizing experienced recovery specialists or coaches, usually matched to the consumer based on age, gender, etc. This 6 month support segment, when implemented, includes very convenient interaction mechanisms such as telephone and text through a mobile application which tracks engagement and progress.

This combined approach provides a collaborative program designed to support the recovering individual via multiple touch points from various specialists making everyone more accountable. The entire program, or portions of it, can be extended as needed based on individual solutions as determined by the healthcare provider.

References:

1While Naltrexone has been approved by FDA in tablet form since 1984 and in injectable form at least since 2006 and is today indicated for treatment of opioid and alcohol addiction, the naltrexone implant has not yet been evaluated for safety and effectiveness by the FDA and is not indicated or approved for treatment of any condition. It is produced under state and federal compounding guidance if prescribed and recommended by a patient’s physician. BioCorRx® does not diagnose, treat, or sell the program or naltrexone implants to patients The determination as to whether, and which, medicine to use for treatment is wholly at the discretion of the physician in consultation with their patient. BioCorRx Pharmaceuticals, a subsidiary of BioCorRx, Inc. is currently pursuing FDA approval of a specific naltrexone implant which is not utilized as part of BioCorRx® Recovery Program.

2Naltrexone or specialized alcohol counseling and effective treatment for alcohol dependence when delivered with medical management (2006, tv1ay 2). Retrieved tv1ay 13, 2015, from https://www.niaaa.nih.gov/news-events/news-releases/naltrexone-or-specialized-alcohol-counseling-effective-treatment-alcohol

BioCorRx® is not a healthcare provider and does not conduct or control counseling sessions. Thus, we cannot guarantee the content, results or number of sessions provided by the independent providers offering our program, nor when they are provided, if at all. Care plans are determined by healthcare provider and patient/consumer.

For more information, please call 888-993-1099

*The BioCorRx® Recovery Program is a medically based program that’s only available from independent medical professionals, but it’s not a cure and doesn’t work for everyone. BioCorRx® does not sell to consumers and does not diagnose or treat individuals. Individual results will vary. Individuals should consult with their physician to determine if the program, or any portion of it, is right for them.

Find Location